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Introduction: Obesity is a major health problem within the population of those with intellectual disabilities. It carries with it a 
number of negative health consequences that lead to, inter alia, overpressure of the blood, carbohydrate-lipid metabolism disturbances, 
diabetes type II, cardiovascular disease and stroke. Many forms of obesity in people with mental disabilities are of a genetic background, 
however, of great importance in its formation is life-style choices and health care system practices.  
Material and methods: This study included 24 people at 24 to 52 years of age, in whom a diagnosis had been made prior to their attaining 
16 years of age, of mild and moderate mental impairment. From these persons, we took venous blood samples (after fasting) in order to obtain 
data on total cholesterol (TC), HDL cholesterol (HDL), LDL cholesterol (LDL), triglycerides (TG), and glucose (GLUC) levels.  
Results: Overweight and obesity were diagnosed in 25% of all women and in 25% of all men, whereas obesity was seen in 16% of 
all women and 23% all men, respectively. A particular problem appeared to be abdominal obesity. This was evident in 41,7% of all 
surveyed (58,3% of all women and 50% of all men). In addition, hypercholesterolemia was common, and was diagnosed in 75% of all 
women and 16.7% of all men. This represented 46% of the total surveyed. 
Conclusions: Our study revealed that environmental factors conducive to mental stimulation, above all, the possibility of em-
ployment, foster motor activity. This positively affects the correct metabolic transformation in people with intellectual disabilities. 
 




Epidemiological studies show that, within medium-
developed and highly developed countries, the state of 
being overweight and obese is a common problem. This 
situation is primarily the result of changes in behaviour 
and lifestyle [1, 2].  
The expansion of the processed food industry has 
led to the prevalence of consumption based on a high 
energy diet rich in fats and carbohydrates [2]. Obesity is a 
problem because of its epidemiological prevalence and 
extent within the population. Despite considerable pro-
gress in the diagnosis, treatment and prevention, cardio-
vascular diseases associated with obesity are a major 
cause of death in the United States and in other indus-
trialised countries [3, 1].   
The World Health Organization (WHO) defines obe-
sity as the excessive accumulation of adipose tissue - this 
being a significant contributor to health deterioration [4]. 
The best and most useful indicator of the state of being 
underweight, overweight or obese, according to the 
WHO, is body mass index (BMI). This is measured by 
dividing the body weight in kilograms, by the square of the 
height specified in meters, (body weight (kg) /height (m2). 
In the case of obesity, this index is equal to or greater than 
30 kg/m2. The state of being overweight is diagnosed when 
the value of the index is equal to or greater than 25.0 kg/m2, 
and an individual is considered underweight when the value 
of the index is less than 18.5 kg/m2 [5]. 
Another indication of excess body weight is waist 
girth - as proposed by the  International  Diabetes  Feder-
ation IDF). This index is useful, particularly in the diagno-
sis of abdominal or celiac obesity, which particularly 
correlates with the disturbances of carbohydrate and 
lipid metabolism which lead to the development of Meta-
bolic syndrome (MS) and type 2 diabetes. This indicator is 
different, depending on the race. In Europe, in the popu-
lation of caucasians, abdominal obesity is diagnosed 
when the waist girth is >= 94 cm in men, while in women, 
this figure is  >= 80 cm [6] . 
The most common adverse obesity effects include: 
disturbances of carbohydrate metabolism, including 
insulin resistance, lipids metabolism disturbances or 
increase in blood pressure. As a result, these dysfunc-
tions contribute, among others, to the formation of 
cardiovascular diseases, respiratory diseases, type 2 
diabetes and depression [7].  
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Table I. The new International Diabetes Federation (IDF) definition of the metabolic syndrome [6]. 
According to the new IDF definition, for a person to be defined as having the metabolic syndrome, they must have, firstly, Central 
obesity (defined as waist circumference* with ethnicity specific values - USA : male ≥ 102 cm, female ≥ 88 cm, Europe: male ≥ 94, 
female cm ≥ 80 cm). If BMI is >30kg/m² (central obesity can be 
assumed and waist circumference does not need to be measured). Secondly, besides central obesity, they must show any two of the 
following four factors: 
Raised 
triglycerides 
≥ 150 mg/dL (1.7 mmol/Lor specific treatment for this lipid abnormality 
Reduced HDL 
cholesterol 
< 40 mg/dL (1.03 mmol/L) in males 
< 50 mg/dL (1.29 mmol/L) in females or specific treatment for this lipid abnormality 
Raised blood 
pressure 
systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg 
or treatment of previously diagnosed hypertension 
Raised fasting pla-
sma glucose 
(FPG) ≥ 100 mg/dL (5.6 mmol/L), 
or previously diagnosed type 2 diabetes 
If above 5.6 mmol/L or 100 mg/dL, OGTT is strongly 
recommended, but is not necessary to define the presence of the syndrome. 
 
 
Abdominal obesity, impaired glucose intolerance, 
hypertriglyceridemia and arterial hypertension are 
included in what is called the metabolic syndrome or 
MS. There are several diagnostic definitions of MS, but 
the latest clinical practice uses two. The first was pro-
posed by   The National cholesterol Education Program's 
Adult Treatment Panel III, NCEP-ATP III (8). According to 
the NCEP-ATP III, metabolic syndrome is observed in 
persons in whom there are at least three out of the five 
components of the definition: abdominal obesity  
(men: >102 cm; women:  >88 cm), triglycerides concentra-
tion above 150 mg/dl (≥1.7 mmol/L), decreased HDL-
cholesterol concentration (men: <40 mg/dl (<1.04 mmol/L); 
women: <50 mg/dl (<1.3 mmol/L), arterial blood pres-
sure above 130/85 mmHg, glucose concentration on 
empty stomach >= 110 mg/dl (>=6.1mmol/l), or recog-
nized diabetes. The criteria of the latest definition of the 
metabolic syndrome as proposed by the International 
Diabetes Federation (IDF), from 2006, are shown in Table I. 
Obesity in adults with mental disabilities also ap-
pears to be a serious problem, but its dissemination is 
different, depending on the country of origin [9]. This is 
indicated by the research carried out in the United States, 
where interest in understanding the combination of 
obesity with mental disabilities is growing steadily. 
Through this interest, it was noticed that the number of 
individuals showing both traits has risen from 19.4% in 
1985, to 34.6% in 2000 [7] . As of the latest available 
data, the obesity indicator in persons with mental disabil-
ities in the UK is approximately 27 %, [10,11], in Ireland - 
32 %, while in Australia, these figures broken down are 
16,3% of all males and 26.5% of all females [7]. It is con-
cluded, therefore, that an increase in body weight is more 
common in women than in men. Poland has not yet been 
carried out research concerning the problem of obesity in 
people with intellectual disabilities. Of further note, the 
tests carried out indicate that obesity prevalence is de-
pendent on degree of mental disability. Excessive adipose 
tissue is more frequent in individuals with mild and 
moderate mental disabilities, than in those with severe 
and deep degrees of the affliction. This is due mainly to 
certain environmental determinants of obesity, such as 
life-style. Research has shown that persons living alone 
or with their families are more susceptible to obesity 
than are those who reside in institutions providing all 
day supervision [12, 7].   
Mental impairment is often accompanied by 
comorbidic diseases, which are inter alia, usually epilepsy 
or mental disorders requiring medical treatment with 
neuroleptics. The prescribed psychotropic drugs for such 
disorders contribute to the increases of body weight, 
especially those from certain groups of second-generation 
medicines [13], the 'atypicals', which after a few months of 
use, induce body weight gain which is on average, 2 to 9 kg. 
This increase in bodyweight does not depend on diurnal 
dose, only on the type of drug [14]. Most second-
generation medicines cause weight gain, with the excep-
tion of molindone, ziprazidone and aripiprazole. With 
regard to the first-generation medicines, otherwise 
known as the 'typicals', disturbing of carbohydrate me-
tabolism is noticeable only after secondary administration 
of chlorpromazine [15, 16].   
In view of the fact that, as so far, in Poland, research 
has not been carried out on ascertaining and understand-
ing the precise relationship between body weight and 
metabolic disorders in adult groups of  persons with men-
tal disabilities, we decided to determine the degree of 
prevalence of overweight and obesity in these people. In 
addition, in order to better understand the reasons for 
this overweight situation being what it is, we attempted to 
determine to what extent sex, lifestyle and environmental 
factors affect body weight gains. Among the factors looked 
at, we included lifestyle, financial situation, physical and 
professional activity. 
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Our aim was to assess the impact of being over-
weight or obese within those with intellectual disabilities, 
including the prevalence of metabolic syndrome, doing so 
on the basis of IDF criteria. Hence, we set out to determine 
whether there is an effect played by environmental fac-
tors and lifestyle on the parameters defining the metabol-
ic syndrome: waist circumference, arterial blood pressure, 
waist circumference, LDL cholesterol, HDL triglycerides, 
total cholesterol and glucose. 
 
Materials and methods  
Initially, the research group consisted of 30 adults 
who were diagnosed as having some degree of mental 
impairment prior to 16 years of age. These were resi-
dents of t e Assisted Living Facility in  Leczna, and the 
Occupational Therapy Workshops in Lublin, as well as 
individuals of the District Vocational Rehabilitation Facil-
ity in Leczna. The main selection criterion was the above-
mentioned mild or moderate mental disability diagnosis, 
consistent with the guidelines set out by ICD-10 [17], as 
well as voluntary participation in all test steps. Each 
person had to sign a voluntary consent form to partici-
pate in the research, in accordance with resolution of 
Bioethics Committee of Medical University of Lublin  
(No KE-0254/101/ 2013). In the case of incapacitated 
persons (two persons), we asked as well, for the written 
consent of their legal guardians. 
The study was divided into several stages: 
 A physical examination. This included the determina-
tion of height, body weight, waist circumference and hip 
circumference, and the intent was to determine the body 
mass index (BMI (body weight (kg) /height (m2) ) and 
WHR Ratio  (waist circumference/hips circumference) [18]. 
Moreover, we twice assessed blood pressure - in the 
morning, within two consecutive days. What is more, we 
undertook a clinical interview with the examined person 
and their legal guardian (to find out about co-existing 
diseases, medications prescribed, and diseases occurring 
in their family). 
 The taking of blood samples for biochemical tests for the 
determination of concentrations of total cholesterol (TC), 
HDL-cholesterol (HDL), LDL cholesterol (LDL), triglycer-
ides (TG), and glucose concentration. These were ob-
tained from venous blood, on an empty stomach (GLUC), 
using standardized methods for the determination. 
 A personal questionnaire which was used to collect 
information about demographics, behaviour (both pro- 
and anti-health), psychosocial functioning and other vari-
ables useful in the study (age, sex, level of education). 
 The return and explanation of the laboratory test 
results and related feedback information. 
The above-mentioned steps involved 27 people, as 
three persons were re-assessed as being severely mental-
ly impaired, hence, they were excluded from the study.  
 
Description of the study group 
Of the 27 individuals, our research used the data 
drawn from 24 persons (n = 24) between the ages of 24 to 
52 years. This study group included 12 women (n = 12) 
and 12 men (n = 12), who were diagnosed as being mildly 
mentally impaired (about 20 people), or moderately men-
tally impaired (four persons) before they had reached 16 
years of age. The average age of the people was 36 years, 
the standard deviation was equal to + /-8,7 year. Of note, 
the age of the women and men differed significantly 
(Mann–Whitney U test, rank sum for women 187,5; the 
rank sum for men 112, 5,  p < 0.03). Among the study 
group, five people (20%) currently had employment in 
the Assisted Living Facility: their source of livelihood was 
both the Disability Living Allowance, as well as remunera-
tion for work. Of these individuals, four persons assessed 
their situation as good, one person thought it to be diffi-
cult. The status of being currently unemployed in the open 
labour market or in supported employment enterprises 
was held by 19 persons (79 %). In addition, four persons 
(16.7%) among all responders, were supported financially 
by way of permanent allowance, while the source of live-
lihood for 13 persons (54%) was the Disability Living 
Allowance. What is more, two persons (8%) drew both a 
disability Living Allowance and a family allowance.  
Regarding their degree of satisfaction with life-style,  
11 people among all responders (46%) considered their 
financial situation as difficult, while 11 persons (46%) 
thought it good and only two people (8%) considered it as 
very good. Furthermore, 14 people had professional train-
ing (58%), six persons (25%) had only primary education, 
one person (4 %) had completed secondary education and 
one person (4%) had had a post-secondary education. In 
addition, fifteen people came from the countryside (62%), 
nine from the city (38%). 
In the subjective assessment of pro-heath behav-
iour, 79% of all participants evaluated themselves as 
physically active (walking, cycling, etc.), among them, one 
person (4%), regularly practised a sport. In addition,  
21 persons (87%) described themselves as being fit, and 
three people (12 %) thought themselves unfit. 
An addiction to smoking was strongly prevalent 
among the responders, as ten persons (42 %) were 
smokers. More than half, 58% of all respondents  
(14 people) also had a co-existing mental disorder, of 
these, 11 persons (46 %) were currently taken a pre-
scribed psychotropic drug (Table II). However, 54% or 
13 people of the study group, were not prescribed any 
medications.  
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Table II. Summary of the psychotropic drugs taken by the 
study group 
Type of drug N % 
Anti-depressants 2 8 
Anti-epileptic 4 16 
Antipsychotic drugs  typical 3 12 
Antipsychotic drugs  atypical 2 8 
 
Statistical analysis 
The obtained results were statistically analyzed us-
ing STATISTICA software, version 10. Testing hypotheses 
was performed by using Mann-Whitney U test. In the case 
of the variables measured on a nominal scale, we used 
the non-parametric chi-squared test with the Yates's 
correction in situations where all the expected numbers 
in the table were >5, and the exact Fischer test, where 
any expected table number was less than 5. The correla-
tion between variables was carried out using Spearman's 
rank correlation coefficient. The results were found to be 
significant at the level of p<0.05. 
 
Results 
Figure 1 shows the distribution of the overweight 
and the obese as measured according to BMI, in the ex-
amined group of people. 




The group of women and men did not differ signifi-
cantly in terms of body mass index (BMI) (Mann-Whitney 
U test), the rank sum for women being 128, while the 
rank sum for men was 172, p< 0.21). Breaking this figure 
down, two women were assessed as being underweight 
(17%), five women (42%) had correct body mass index, 
three women (25%) were overweight, one woman (8%) 
was obese class I, and one woman (8%) was obese class 
II. In the men's group, the distribution of body mass 
index BMI was as follows: six men (50%) had normal 
body mass index, three (25%) were assessed as over-
weight, two (17%) were obese class I, one man (8%) was 
obese class III. Taking into account the entire study 
group, obese patients comprised 20% of the total, while, 
an overweight assessment, according to the BMI, was 
diagnosed in 25% of the total surveyed. 
Abdominal obesity measured by the WHR ratio, was 
found in ten people (42% of all tested): six women (50% 
of all women) and four men (33% of all men). An inter-
pretation of waist circumference according to the guide-
lines proposed by the IDF generated different figures. Of all 
women, seven (58%) was diagnosed as having abdominal 
obesity, of all men, six people (50%) had a waist circumfer-
ence greater than 94 cm (indicating abdominal obesity). 
Regarding the metabolic syndrome, three persons 
(12.5% of the total surveyed) were diagnosed as having 
this (by meeting three criteria), more specifically, one 
women (8%) and two men (17%). A statistical analysis 
did not reveal any differences between men and women 
in the number of identified criteria of the metabolic syn-
drome (Mann-Whitney U test, rank sum for women - 145, 
the rank sum for men - 155, p< 0.79). Ten persons, how-
ever, (42% of the total surveyed) showed none of the 
criteria of the metabolic syndrome. An accurate summary 
is shown in Figure 2. 
 
Figure 2. The co-existence of diagnostic criteria of the 
metabolic syndrome among the study group. From num-
ber 1 to 11: women; from 12 to 24: men. A number of 
criteria ≥3 means recognized metabolic syndrome. 
 
 
The differences between individuals with abdominal 
obesity and without abdominal obesity in the tested 
group of persons, reached statistical significance in terms 
of age, body weight, BMI, systolic blood pressure and 
diastolic pressure. This means that people with abdominal 
obesity had a significantly higher BMI (body mass index) 
(The Mann-Whitney U test, rank sum for persons with 
abdominal obesity was 229. The rank sum for persons 
without abdominal obesity was 71, p< 0.00). 
Of those characterised by a higher arterial pressure, 
regarding systolic pressure - Mann-Whitney U test, rank 
sum for persons with abdominal obesity was 207, the rank 
sum for persons without abdominal obesity was 92, p<0,00; 
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and diastolic blood pressure - Mann- Whitney U test, rank 
sum for persons with abdominal obesity was 202, the 
rank sum for persons without abdominal obesity was 97, 
p< 0.02. These dependencies increase with age (Mann-
Whitney U test, rank sum for people with abdominal 
obesity - 203, rank sum for persons without abdominal 
obesity - 95, p< 0.01). 
No significant differences were observed between LDL 
cholesterol, HDL, total cholesterol, triglycerides and glucose 
in people with abdominal obesity and those without. 
To determine higher lipid and lipoprotein concentrations 
in the plasma, we utilised the classification seen in the 
WOBASZ program:  hypercholesterolemia - LDL >= 3.0 mmol/l 
(115 mg/dl) or TC >= 5.0 mmol/l (190 mg/dl) and hypertri-
glyceridemia - TG >= 1.7 mmol/l (150 mg/dl) [19]. The 
figures employed in assessing aterogenic dyslipidemia 
(which is associated with increased concentration of 
triglycerides) were - TG >= 1.7 mmol/l (150 mg/dl) and 
low HDL concentration - women <1.2 mmol/l (45 mg/dl), 
- men < 1.0 mmol/l (40 mg/dl) [20].  
The hypercholesterolaemia prevalence in the study 
group was 46%, and was also assessed in the individuals 
who were considered underweight. What is interesting, 
nine out of the twelve women were (75%) were 
hypercholesterolaemia, while most men (i.e., eight out of 
the twelve surveyed  or 66%) had standard LDL and total 
cholesterol concentration. Furthermore, an aterogenic 
dyslipidemia optimal was found in one man (8% of the 
total examined) who had also been diagnosed with metabolic 
syndrome. Regarding hypertriglyceridemia, an increased 
level of triglycerides was observed in one women (8%) and 
in two men (17%), and reduced HDL-cholesterol level was 
observed in two women (17%) and in three men (25%). 
Increased LDL cholesterol concentration, total cholesterol, 
triglycerides and reduced HDL was also evident in the 
group of persons without abdominal obesity, and even in 
persons who were underweight. In establishing whether 
or not psychotropic drugs affect the body weight, blood 
pressure levels, glucose and cholesterol levels, in the 
examined group, 14  persons (58% of the total examined) 
were afflicted with an associated mental disorder, of 
which 11 persons (46%) regularly took prescribed psy-
chotropic drugs, the majority were women.  
Of note, the anthropometric measurements: body 
weight, body mass index BMI, obesity index WHR, were signif-
icantly higher in the group of persons not receiving prescribed 
psychotropic drugs (body weight: Mann-Whitney U test, rank 
sum of people not receiving medication - 206, rank sum of 
people taking medication - 94, p<0,01; BMI- Mann-Whitney U 
test, rank sum of people not receiving medication - 198, rank 
sum of people taking medication -102, p<0,04; WHR - Mann-
Whitney U test, rank sum of people not receiving medication - 
203, rank sum of people taking medication - 97, p< 0.02).  
In both sexes, there are no demonstrated significant 
differences in cholesterol concentration, glucose in se-
rum and arterial blood pressure with respect to taking or 
not taking prescribed psychotropic drugs. 
Table III and IV show correlations between the 
various factors of age, body weight, BMI, waist circum-
ference, WHR, systolic pressure, diastolic BP, fasting 
glucose level, cholesterol HDL, LDL, triglycerides, total 
cholesterol, sex distribution. 
Our study revealed that in the women's group, high 
correlations exist between systolic pressure and body 
weight (rs 0, 77, p< 0.05), BMI (rs 0, 76, p< 0.05), waist 
circumference (rs 0, 80, p< 0.05) and WHR ratio (rs 0, 71, 
p< 0.05), which increased with age. In men, however, it 
was found that, together with the increase in body weight 
and BMI index, decreased cholesterol HDL existed (body 
weight & HDL, rs= -, 060, p< 0.03; BMI & HDL, rs= -0, 61, 
p< 0.03). Such dependencies were not detected in the 
women's group. 
Research revealed that the persons who consid-
ered themselves as being physically active have lower 
total cholesterol in the blood, in comparison to people 
who thought themselves physically inactive (Mann- 
WhitneyU test, rank sum for active 41, rank sum for 
physically inactive - 37, p< 0.01). In our research, we 
observed differences between residents of rural and 
urban areas. The rural inhabitants had higher blood 
glucose concentrations (Mann-Whitney U test, rank sum 
for rural residents - 153, rank sum for urban residents - 
146, p< 0.04), higher total cholesterol (Mann-Whitney U 
test, rank sum for rural residents - 223, rank sum for 
urban residents - 77, p< 0.03) and higher LDL cholester-
ol (Mann-Whitney U test, rank sum for rural  residents - 
223, rank sum for urban residents - 76, p< 0.03).  It was 
also found that people currently working have lower 
blood glucose concentration, in comparison to persons 
who were unemployed (Mann-Whitney U test, rank sum 
for persons working  - 204, rank sum for the unem-
ployed  - 96, p< 0.01). 
The study results reveal as well that persons em-
ployed have significantly lower total blood cholesterol, in 
comparison to those unemployed (Mann-Whitney U test, 
rank sum for those who ever were employed - 78, rank 
sum for long-term unemployed  - 222, p< 0.04), and they 
were primarily from the urban population (67% of the 
total examined). Interestingly, these persons, to a lesser 
extent, had abdominal obesity - as measured using waist 
circumference according to IDF, as well as by the WHR 
ratio. This was of statistical significance, showing a mod-
erate relationship (waist circumference, Fischer's exact 
test, p<0,05, Fi Yuel's indicator  - 0.50; WHR ratio, Fisch-
er's exact test, p<0,05, Fi Yuel's indicator  - 0,48). 
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Table III. Correlations of Spearman's rank in the group of women, between the age, body weight, BMI, and WHR, and 
arterial blood pressure, glucose, HDL-cholesterol, LDL, as well as total and triglycerides. Marked coordinates of correla-
tion are significant at p < ,05000 
 N R - Spearman t(N-2) p 
Age & body weight * 12 0,597548 2,35661 0,040185 
Age & BMI * 12 0,636213 2,60771 0,026143 
Age & Waist circumference* 12 0,656694 2,75360 0,020352 
Age & WHR* 12 0,797902 4,18587 0,001870 
Age & Systolic pressure * 12 0,666078 2,82393 0,018039 
Age & LDL cholesterol * 12 0,697187 3,07537 0,011733 
Body weight & Systolic pressure * 12 0,773297 3,85680 0,003177 
Body weight & Diastolic pressure * 12 0,795794 4,15565 0,001962 
Body weight & HDL cholesterol 12 -0,573427 -2,21339 0,005126 
Weight & Triglycerides 12 0,503497 1,84282 0,095157 
BMI & Age * 12 0,636213 2,60771 0,026143 
BMI & Systolic pressure * 12 0,766267 3,77131 0,003654 
BMI & Diastolic pressure * 12 0,806358 4,31148 0,001534 
BMI & Glucose on empty stomach 12 0,489510 1,77520 0,106252 
BMI & HDL cholesterol 12 -0,510490 -1,87736 0,089914 
BMI & LDL cholesterol 12 0,273205 0,89812 0,390234 
BMI & Total cholesterol 12 0,097902 0,31109 0,762122 
BMI & Triglycerides 12 0,419580 1,46172 0,174519 
Waist circumference & Systolic *pressure * 12 0,801061 4,23196 0,001738 
Waist circumference & Diastolic pressure * 12 0,784843 4,00503 0,002498 
Waist circumference & Glucose on empty stomach 12 0,409808 1,42070 0,185824 
Waist circumference & HDL cholesterol 12 -0,553416 -2,10115 0,061958 
Waist circumference & LDL cholesterol 12 0,287719 0,95002 0,364497 
Waist circumference & Total cholesterol 12 0,108582 0,34541 0,736944 
Waist circumference & Triglycerides 12 0,469353 1,68087 0,123706 
WHR & Systolic pressure * 12 0,713542 3,22064 0,009165 
WHR & Diastolic pressure  12 0,545788 2,05978 0,066412 
WHR & Glucose on empty stomache 12 0,321678 1,07434 0,307910 
WHR & HDL cholesterol 12 -0,300699 -0,99704 0,342260 
WHR & LDL cholesterol 12 0,504379 1,84716 0,094485 
WHR & Total cholesterol 12 0,349650 1,18018 0,265239 
WHR & Triglycerides 12 0,391608 1,34587 0,208063 
 
Table IV. Correlations of Spearman's rank in the group of men, between the age, body weight, BMI, and WHR, and arte-
rial blood pressure, glucose, HDL-cholesterol, LDL, as well as total and triglycerides 
 N R - Spearman t(N-2) p 
Age & Body weight  12 0,515930 1,90457 0,085972 
Age & BMI  12 0,339242 1,14040 0,280695 
Age & Waist circumference 12 0,497365 1,81294 0,099921 
Age & WHR 12 0,544200 2,05126 0,067367 
Age & Systolic pressure  12 0,170820 0,54824 0,595555 
Age & LDL cholesterol  12 0,000000 0,00000 1,000000 
Body weight & Systolic pressure  12 0,281697 0,92840 0,375065 
Body weight & Diastolic pressure  12 0,136603 0,43606 0,672054 
Body weight & HDL cholesterol* 12 -0,601399 -2,38036 0,038588 
Weight & Triglycerides 12 0,559441 2,13436 0,058589 
BMI & Age  12 0,339242 1,14040 0,085972 
BMI & Systolic pressure 12 0,359164 1,21698 0,251553 
BMI & Diastolic pressure 12 0,220666 0,71544 0,490702 
BMI & Glucose on empty stomach 12 -0,097902 -0,31109 0,762122 
BMI & HDL cholesterol* 12 -0,615385 -2,46885 0,033170 
BMI & LDL cholesterol 12 0,175440 0,56353 0,585489 
BMI & Total cholesterol 12 0,335664 1,12684 0,286123 
BMI & Triglycerides 12 0,447552 1,58264 0,144586 
Waist circumference & Systolic pressure 12 0,352739 1,19208 0,260750 
Waist circumference & Diastolic pressure 12 0,203509 0,65731 0,525823 
Waist circumference & Glucose on empty stomach 12 -0,136603 -0,43606 0,672054 
Waist circumference & HDL cholesterol 12 -0,553416 -2,10115 0,061958 
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c.d. Table IV. Correlations of Spearman's rank in the group of men, between the age, body weight, BMI, and WHR, and 
arterial blood pressure, glucose, HDL-cholesterol, LDL, as well as total and triglycerides 
 N R - Spearman t(N-2) p 
Waist circumference & LDL cholesterol 12 0,217927 0,70612 0,496238 
Waist circumference & Total cholesterol 12 0,395797 1,36292 0,202808 
Waist circumference & Triglycerides 12 0,532400 1,98891 0,074756 
WHR & Systolic pressure 12 0,119721 0,38133 0,710932 
WHR & Diastolic pressure 12 -0,028021 -0,08865 0,931114 
WHR & Glucose on empty stomach 12 -0,363636 -1,23443 0,245265 
WHR & HDL cholesterol 12 -0,496503 -1,80878 0,100603 
WHR & LDL cholesterol 12 0,400002 1,38014 0,197614 
WHR & Total cholesterol 12 0,531469 1,98406 0,075362 
WHR & Triglycerides 12 0,349650 1,18018 0,265239 
 
Discussion 
A literature search reveals that the mentally disa-
bled in many countries are overweight or obese. This 
situation is reflected in our results. Those assessed as 
either overweight or obese were 49% of the examined, of 
which 21% were people who were obese, the other 28% 
were people who were overweight. In Poland, so far, 
there is little or no data on the prevalence of such situa-
tions in people with mental disabilities. However, a com-
prehensive analysis in this respect has been carried out 
in a population of healthy individuals. The most im-
portant research includes the NATPOL PLUS, WOBASZ, 
IDEA POLAND and PONS STUDY (The Polish Norwegian 
Study) [21, 22, 23, 24].  
According to statistics presented in the IDEA 
POLAND study, 2/3 of all adult patients coming to prima-
ry care doctors are either overweight or obese. In our 
study, t e figure was ½ of t e total test population [23]. 
However, the limited size of the study population ensures 
that this figure is unreliable. It should be noted, however, 
that in the study, a diagnosis of overweight was more 
common that an assessment of obesity. Moreover, the 
average age of patients was relatively low at 36 years 
(standard deviation + /-8,7 years). 
In the NATPOL PLUS study, 28.5% of all women and 
39,1% of all men were overweight, while 19,3% of women 
and 18.9 % of men were obese. According to the IDEA 
POLAND study, these indicators were: overweight, 32.6% 
of all women, 40.8% of all men; obese, 32,7% of all wom-
en and all men [22, 23]. In our study, these indicators 
were slightly lower and as follows:  overweight was diag-
nosed in 25% of all women and men, and obesity was 
assessed in 16% of all women and 23% of all men. As in 
the research on the mentally healthy population, the 
number of men designated as obese was greater than the 
number of women assessed so. In relation to existing 
research carried out the mentally disabled population, our 
degree of obesity assessment was similar to that obtained 
in the UK (27 %) and Ireland (32 %) [10,11].   It should be 
noted that our study had a test population consisting of 
individuals diagnosed as having mild or moderate mental 
disabilities. According to available literature, such a state 
seems to favour the disposition of excessive adipose tis-
sue, which translates to greater freedom of life [12, 7]. Our 
test population enjoyed great personal freedom, some 
even ran their own households. Moreover, all were partic-
ipants within daily assisted-living centres, or home sup-
port establishments or supported employment enterpris-
es. In all these living situations, importance is given to 
health education and social development. 
One of the main goals of our study was to look at the 
issue of metabolic syndrome as present within the intel-
lectually disabled. So far, in Poland, little work has been 
done on this issue. Indeed, world-wide there is not much 
literature on the combination of the metabolic syndrome 
and reduced cognitive functions. However, a Japanese 
study consisting of a group of 302 patients diagnosed as 
being mental disabled shows that 13.6% of the entire 
study population was co-assessed as displaying the meta-
bolic syndrome (diagnosed on the basis of NCEP-ATP III 
definitions), more often, this was seen in the male part of 
the test population [13].   A Dutch study conducted in a 
group of mentally disabled persons over 50 years of age, 
has shown that the prevalence of the metabolic syndrome 
(MS) in the mentally disabled is greater than in a popula-
tion without such illnesses. Their estimation amounted to 
25,1%. Furthermore, MS was observed more frequently in 
persons with mild cognitive disabilities [25].   
In our study, 12.5% of the study population was as-
sessed as showing the metabolic syndrome.  
Similarly to the Japanese studies, most of these indi-
viduals were men (17% versus 8% of all women). Empha-
sis in scrutinizing these results should be placed upon the 
age factor. In our study, the general age of the test popula-
tion was low. Moreover, all had benefited or are benefiting 
from institutional aid, where caregivers pay attention to 
potential health problems. 
Research in Poland within the general population 
has revealed that the prevalence indicator of MS is esti-
mated to be 20% (NATPOL PLUS research, by NCEP-ATP 
III criteria) to 39,5 % (PONS STUDY research, according to 
IDF criteria), and this indicator increases as the age of 
U. Łopuszańska, K. Skorzyńska-Dziduszko, R. Mlak, K. Kryś-Noszczyk, K. Lupa-Zatwarnicka, M. Makara-Studzińska 
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patients increases. According to the PONS STUDY, within 
the youngest age group (45-49 years), this figure was 
27%, and in the oldest age group (60-64 years), this figure 
rose to 47,1% [22,24]. However, attention should be paid 
to the regional differences in these figures. The WOBASZ 
study (criteria based upon NCEP-ATP III definitions), puts 
forward that the highest percentage figure was recorded 
in Wielkopolskie voivodeship (33% of all men), and the 
lowest in the Lubelskie voivodeship (16% of all men) and 
Podkarpackie voivodeship (17% of all women). Similarly 
to research in other countries, it was noted that the likeli-
hood of MS occurrence increases with age, particularly in 
women [21]. Thus, the results obtained in our study in the 
male group are similar to that obtained in the Lubelskie 
voivodeship according to the WOBASZ study. 
One of the components of the metabolic syndrome is 
abdominal obesity. This carries with it a number of nega-
tive consequences. In our research, 41,7% of the entire 
study group were assessed with abdominal obesity. In 
women, this indicator was 58.3%, in men - 50% (the 
criteria according to IDF). According to research conduct-
ed in Poland, in 2004, by NATPOL PLUS within the general 
population, abdominal obesity appeared in 37% of all 
women and 20% of all men. More recent research by IDEA 
POLAND, dating from 2011, indicates that this problem is 
has been exacerbated significantly, as on the basis of the 
NCEP-ATP III criteria, abdominal obesity was seen in 54 
% of  all women and 37% of all men.  
Our results have shown that abdominal obesity is 
quite evident among the mentally disabled, but the gender 
differences in degree of  MS presence is less clear than 
that within these other studies of general population. 
More or less, however, the figures mirror that of the other 
studies in that persons with an increased waist circumfer-
ence had associated health problems such as  hypertension, 
overweight and obesity, all of which increase with age. 
In addition, it seems that hypercholesterolemia 
(46% of the total examined) was a major problem in the 
examined group.  Our results were compared with that 
obtained previously in the area of Lublin by way of the 
WOBASZ study [19]. In this comparison, hypercholester-
olemia was more significantly prevalent in the group of 
mentally disabled women (75%), than in the group of 
women (51%) drawn from the general population. Simi-
larly, a significant difference was seen in our study group 
results in regard to lower HDL cholesterol concentration 
in the male population – at 25% of the total population 
versus 9% in the general population. 
The limited size of the test group, must be taken into 
account, but the  results of the study is of some concern 
regarding hypercholesterolemia, as the age of the study 
group was low. It is believed that this figure came about 
due to  the duel nature of mental disability and the pres-
ence of associated mental diseases. Certain antipsychotic 
drugs (particularly second generation or 'atypicals') affect 
body weight and blood glucose levels. Because the study 
group was small, the obtained figures are not reliable.  
It is possible that the reason for the higher degree of 
hypercholesterolaemia among our  study group is due to 
environmental factors. As indicated earlier, differences in 
the level of LDL cholesterol and blood glucose between 
the rural population and the urban population indicate 
that diet, health awareness and degree of employment 
influence these figures. Our study saw that lower blood 
glucose concentration and lower total cholesterol concen-
tration were evident amongst those with gainful employ-
ment, or who had experienced gainful employment.  
In addition, those with gainful employment or who 
had experienced gainful employment showed to a lesser 
extent, abdominal obesity and lower total blood choles-
terol. Our study saw that such individuals were rural 
dwellers and had better access to work and various voca-
tional/ occupational development programs for disabled 
people. There is reason to believe, therefore,  that work 
possibilities, and, hence, increases in social and physical 
activity has a beneficial effect on metabolic parameters. 
 
Conclusions  
Persons with mild and moderate mental disabilities 
were found to be, to a greater extent, overweight, to show 
abdominal obesity and have hypercholesterolaemia, in 
relation to the the general population. The degree of dis-
play of the metabolic syndrome was, however, similar. It 
is believed that the prevalence of metabolic disorders is 
dependent on life-style, environment influences and voca-
tional activity.  
The problem of overweight, abdominal obesity and 
hypercholesterolaemia among the mentally disabled 
requires further detailed research on a wider scale, taking 
account the distribution of persons inside society, their 
access to institutional aid, and their living conditions 
(whether living alone or with family or those considered 
family). We feel that special attention must be paid to 
environmental factors, which as demonstrated in our 
preliminary study, have significant impact on the state of 
health. It seems that the existence of possibilities for pro-
fessional or work development has major effects on 
health.  In the interests of disabled people and their fami-
lies, but first and foremost in the interests of our health 
care system, support must, therefore, be given to these 
people so as to ensure their independence. 
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